The AZNCF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AZNCF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AZNCF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AZNCF Detailed Price Forecast - CNN Money||View AZNCF Detailed Summary - Google Finance|
|View AZNCF Detailed Summary - Yahoo! Finance||View AZNCF Stock Research & Analysis - Zacks.com|
|View AZNCF Trends & Analysis - Trade-Ideas||View AZNCF Major Holders - Barrons|
|View AZNCF Call Transcripts - NASDAQ||View AZNCF Breaking News & Analysis - Seeking Alpha|
|View AZNCF Annual Report - CompanySpotlight.com||View AZNCF OTC Short Report - OTCShortReport.com|
|View AZNCF Fundamentals - TradeKing||View AZNCF SEC Filings - Bar Chart|
|View Historical Prices for AZNCF - The WSJ||View Performance/Total Return for AZNCF - Morningstar|
|View the Analyst Estimates for AZNCF - MarketWatch||View the Earnings History for AZNCF - CNBC|
|View the AZNCF Earnings - StockMarketWatch||View AZNCF Buy or Sell Recommendations - MacroAxis|
|View the AZNCF Bullish Patterns - American Bulls||View AZNCF Short Pain Metrics - ShortPainBot.com|
|View AZNCF Stock Mentions - StockTwits||View AZNCF Stock Mentions - PennyStockTweets|
|View AZNCF Stock Mentions - Twitter||View AZNCF Investment Forum News - Investor Hub|
|View AZNCF Stock Mentions - Yahoo! Message Board||View AZNCF Stock Mentions - Seeking Alpha|
|View Insider Transactions for AZNCF - SECform4.com||View Insider Transactions for AZNCF - Insider Cow|
|View AZNCF Major Holdings Summary - CNBC||View Insider Disclosure for AZNCF - OTC Markets|
|View Insider Transactions for AZNCF - Yahoo! Finance||View Institutional Holdings for AZNCF - NASDAQ|
|View AZNCF Stock Insight & Charts - FinViz.com||View AZNCF Investment Charts - StockCharts.com|
|View AZNCF Stock Overview & Charts - BarChart||View AZNCF User Generated Charts - Trading View|
Long-Term Investors Take Note -- These 5 Big Pharma Companies Have the Best Pipelines
Posted on Sunday June 24, 2018
These drugmakers arguably have the strongest pipelines. But are they all great stocks to buy?
Lynparza Could Be Merck’s Long-Term Growth Driver
Posted on Wednesday June 20, 2018
Merck & Company (MRK) and AstraZeneca (AZN) jointly develop and commercialize Lynparza. In June, Merck and AstraZeneca presented data from the Study 08 trial, in which a combination of Lynparza and abiraterone demonstrated an improvement in median radiologic progression-free survival (or rPFS) compared to abiraterone monotherapy.
Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals
Posted on Friday June 15, 2018
Eli Lilly (LLY)/AstraZeneca (AZN) discontinue two late-stage studies on Alzheimer's disease candidate, lanabecestat. Merck's Keytruda gets FDA nod for two new indications.
[$$] Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer’s Drug Trials
Posted on Tuesday June 12, 2018
AstraZeneca PLC and Eli Lilly & Co. on Tuesday scrapped two late-stage trials of an experimental Alzheimer’s drug they were co-developing, the latest blow in the long quest to find a breakthrough for the memory-robbing disorder. The companies said the decision was taken after an independent data-monitoring committee concluded that trials associated with lanabecestat, the experimental drug, wouldn’t achieve their original goals. An AstraZeneca spokesman said the two will continue to jointly pursue an early-stage trial of another experimental Alzheimer’s drug.